Home/Pipeline/Not specified in provided content

Not specified in provided content

Oncology

VariousActive

Key Facts

Indication

Oncology

Phase

Various

Status

Active

Company

3Sbio, 3Sbio, 3Sbio, 3Sbio

About 3Sbio

Leading Chinese biopharma company developing innovative biologics for oncology, immunology, nephrology, and dermatology with full-cycle R&D capabilities.

View full company profile

About 3Sbio

Leading Chinese biopharma company developing innovative biologics for oncology, immunology, nephrology, and dermatology with full-cycle R&D capabilities.

View full company profile

About 3Sbio

Leading Chinese biopharma company developing innovative biologics for oncology, immunology, nephrology, and dermatology with full-cycle R&D capabilities.

View full company profile

About 3Sbio

Leading Chinese biopharma company developing innovative biologics for oncology, immunology, nephrology, and dermatology with full-cycle R&D capabilities.

View full company profile

Therapeutic Areas

Oncology Immunology Nephrology Dermatology

Other Oncology Drugs

Drug	Company	Phase	Status
Bi-XDC with PROTACs	Coherent Biopharma	IND-enabling	Active
Bi-XDC with RPT	Coherent Biopharma	Early-stage	Active
mRNA Anticancer Vaccine	Sunshine Biopharma	Preclinical Research	Active
Biosimilar Bevacizumab	Organon (2)	Phase 3	Active
Biosimilar Pembrolizumab	Organon (2)	Phase 3	Active
BCL-2 Inhibitor Program	Vincerx Pharma	Preclinical	Research
Preclinical Projects	Zion Pharma	Preclinical	Active
Attenukine Oncology Candidate	Teva	Phase 1	Active
XEMA Tumor Marker ELISA Kit	XEMA Group	Commercial	Active
KRAS inhibitor	Risen Pharma Tech	Preclinical/Phase 1	Active (AACR 2024 presentation)
KEAP1 Activator Program	Vividion Therapeutics	Phase 1	Active
Bendamustine Intermediate	AR Life Science	Commercial	Active